Is to provide cellular storage solutions for life-saving applications by greatly enhancing the handling of critical perishable biological components such as blood components, bone marrow, stem cells and transplant organs.
Revolves around the effect of the noble gas xenon (Xe) on biological cells.
Is to develop practical solutions for the preservation of biological tissues.
Our Competitive Advantage
Is our proprietary platform technology to protect human cells.
Our Commitment to Patients
Is to continue to develop life-saving applications for those who most benefit from our cutting-edge technology: cancer patients, major surgical patients and people with blood disorders.
Meet the Management Team
John is a seasoned executive with more than 30 years of experience in the biopharmaceutical/medical technology industry, where he has held senior executive positions. He was the CEO of ONY Biotech and the CEO of Shore Therapeutics. In addition, he drove the early commercialization of Genentech and Acorda Therapeutics. In each of his previous roles, John’s integral participation resulted in the company’s successful growth.
Ilya Ilyin, PhD, MBA
Ilya is R&D leader with 20+ years of experience involving new product and technology development and implementation. Prior to CPT he was a Senior Principal at GEN3 Partners, where he helped Fortune 500 companies build a process and culture for innovation. He has significant experience in delivering practical solutions that have been adopted by world's most recognized companies. With a background in bioengineering, he is an author of more than 15 patents, many articles and a textbook chapter.
Suresh Lakshmanan, DDS, PhD
Dr. Suresh is a world class scientist, with broad experience in oral surgery, immunology, diagnostics and pathology. He is an author of multiple publications and book chapters, holds several patents, and has research collaborations around the world. He holds an academic appointment at the State University of NY at Buffalo, and is licensed to practice oral surgery in the UK.
Get in touch and we’ll get back to you as soon as we can. We look forward to hearing from you!